Notice of intent to single source boehringer ingelheim animal health USA, INC
Closed State & local contract opportunity
- Solicitation number
- PUR 9967
- State
- Florida
- Responses due
Opportunity facts
- Jurisdiction
- UNSPSC codes
- 51204200 Veterinary vaccines and virology products
- 10111305 Medicated pet treatments
- 42121601 Gastrointestinal veterinary products
- 51204205 Ovine rinderpest or peste des petit ruminants vaccines
- 42121600 Veterinary products
- 51204201 Veterinary foot and mouth disease (FMD) vaccines
- 51204202 Veterinary anthrax vaccines
- 52141705 Parts of shavers or hair removers
- 42121602 Blood or blood forming veterinary products
- 42121603 Respiratory system veterinary products
Show all 17
- 42121604 Musculo skeletal or nervous system veterinary products
- 42121605 Cardiovascular system veterinary products
- 42121606 Dermatological or antiprotozoa veterinary products
- 42121607 Genito urinary system sex or hormone veterinary products
- 51201808 Levamisole or tetramisole
- 51204203 Veterinary brucella vaccines
- 51204204 Contagious bovine pleuropneumonia CBPP vaccines
- Point of contact
-
- Radoslava Edreva radoslava.edreva@colliercountyfl.gov (239) 252-8374
Opportunity details come from procurement.opengov.com. Updated .
About this opportunity
Collier County, Florida is pursuing a single-source procurement for animal health products from Boehringer Ingelheim Animal Health USA, Inc., spanning a procurement period from May 27, 2025, to January 31, 2027. The procurement specifically targets FDA-approved veterinary pharmaceuticals and vaccines, including HEARTGARD Plus (heartworm prevention), NexGard (flea and tick protection), NexGard PLUS, NexGard COMBO, RECOMBITEK Canine Vaccines, PUREVAX Feline Vaccines, and IMRAB rabies vaccines. The county's Procurement Services Division is seeking these products through a single-source acquisition, with a submission deadline of June 3, 2025, at 3:00 pm. The procurement objectives include obtaining discounted pricing through the Partners in Protection Shelter Program Participation Agreement. Potential respondents are invited to provide alternative vendor information if they believe other qualified sources exist, with all submissions to be made through the Collier County Procurement Services Online Bidding System.
The procurement appears to have no specific set-aside designations or restrictions on responding organizations. Boehringer Ingelheim is positioned as the sole manufacturer of these specific animal health products, which serves as the primary justification for the single-source approach. The county explicitly reserves the right to make the final determination on the sole/single source designation and instructs respondents not to include pricing information in their responses. While specific award values are not detailed in the documentation, the procurement covers a range of veterinary pharmaceutical and vaccine products for animal health protection. The procurement approach suggests a targeted acquisition focused on obtaining specialized, FDA-approved animal health products through a manufacturer with exclusive production capabilities.
Opportunity text
Description of Intended Products or Services Provided:
Boehringer Ingelheim Animal Health USA Inc. is the sole manufacturer of HEARTGARD Plus, which is approved by the Federal Drug Administration to prevent heartworm disease in dogs as well as treat and control roundworms and hookworms; NexGard, which is approved by the Federal Drug Administration to protect dogs against fleas and ticks and prevent Lyme disease by killing black-legged ticks; NexGard PLUS which is approved by the Federal Drug Administration to protect dogs against fleas and ticks, prevent heartworm disease, and treat and control roundworms and hookworms; NexGard COMBO which is approved by the FDA for use in cats to kill fleas and ticks, prevent heartworm disease, and treat and control roundworms, hookworms, and tapeworms; RECOMBITEK Canine Vaccines; PUREVAX Feline Vaccines; and IMRAB rabies vaccines.
Discounted pricing will be provided through the Partners in Protection Shelter Program Participation Agreement with Boehringer Ingelheim Animal Health USA, Inc.
Files
| File | Type | Posted |
|---|---|---|
| NOTICE_OF_INTENT_TO_SINGLE_SOURCE_BOEHRINGER_INGELHEIM_ANIMAL_HEALTH_USA,_INC.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity